AMPLIPHI BIOSCIENCES CORP (APHB) Stock Price & Overview

NYSEARCA:APHB

Current stock price

0.3179
-0.08 (-20.33%)
At close:
0.312
-0.01 (-1.86%)
After Hours:

The current stock price of APHB is 0.3179 null. Today APHB is down by -20.33%. In the past month the price increased by 9.62%. In the past year, price decreased by -71.1%.

APHB Key Statistics

52-Week Range0.15 - 1.37
Current APHB stock price positioned within its 52-week range.
1-Month Range0.281 - 0.445
Current APHB stock price positioned within its 1-month range.
Market Cap
10.64M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.64
Dividend Yield
N/A

APHB Stock Performance

Today
-20.33%
1 Week
-16.34%
1 Month
+9.62%
3 Months
+27.16%
Longer-term
6 Months +5.97%
1 Year -71.10%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

APHB Stock Chart

AMPLIPHI BIOSCIENCES CORP / APHB Daily stock chart

APHB Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to APHB. When comparing the yearly performance of all stocks, APHB is a bad performer in the overall market: 85.39% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
APHB Full Technical Analysis Report

APHB Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to APHB. Both the profitability and financial health of APHB have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
APHB Full Fundamental Analysis Report

APHB Earnings

Next Earnings DateN/A
Last Earnings DateN/A
APHB Earnings History

APHB Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y29.69%
Revenue Next YearN/A
APHB Forecast & Estimates

APHB Financial Highlights

Over the last trailing twelve months APHB reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS increased by 60.25% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-12.59M
Industry RankSector Rank
PM (TTM) N/A
ROA -130.95%
ROE -253.84%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%40%
Sales Q2Q%N/A
EPS 1Y (TTM)60.25%
Revenue 1Y (TTM)-100%
APHB financials

APHB Ownership

Ownership
Inst Owners6.4%
Shares33.47M
Float32.13M
Ins Owners0.08%
Short Float %N/A
Short RatioN/A
APHB Ownership

About APHB

Company Profile

AmpliPhi Biosciences Corporation, formerly known as Targeted Genetics Corporation, is a biotechnology company which develops anti-bacterial solutions for the treatment of gram negative bacterial infections that are often resistant to existing antibiotic treatments. AmpliPhi Biosciences Corporation is based in Seattle, Washington.

Company Info

AMPLIPHI BIOSCIENCES CORP

3579 VALLEY CENTRE DRIVE SUITE 100

SAN DIEGO CA 92130

CEO: Paul C. Grint

Phone: 804-827-2524

AMPLIPHI BIOSCIENCES CORP / APHB FAQ

What does AMPLIPHI BIOSCIENCES CORP do?

AmpliPhi Biosciences Corporation, formerly known as Targeted Genetics Corporation, is a biotechnology company which develops anti-bacterial solutions for the treatment of gram negative bacterial infections that are often resistant to existing antibiotic treatments. AmpliPhi Biosciences Corporation is based in Seattle, Washington.


What is the current price of APHB stock?

The current stock price of APHB is 0.3179 null. The price decreased by -20.33% in the last trading session.


What is the dividend status of AMPLIPHI BIOSCIENCES CORP?

APHB does not pay a dividend.


How is the ChartMill rating for AMPLIPHI BIOSCIENCES CORP?

APHB has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the Price/Earnings (PE) ratio of AMPLIPHI BIOSCIENCES CORP (APHB)?

AMPLIPHI BIOSCIENCES CORP (APHB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.64).


What is the ownership structure of AMPLIPHI BIOSCIENCES CORP (APHB)?

You can find the ownership structure of AMPLIPHI BIOSCIENCES CORP (APHB) on the Ownership tab.